GlassScriptPhysician profile
Sachiko Arakawa
NPI 1942853312
$754.69
in general payments reported to CMS, 2019-2025
14 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $142 · 2022: $241 · 2023: $185 · 2024: $52.95 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349 · Education: $22.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.94 |
| Education | $22.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $117.46 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $113.33 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $67.97 | 2022-2023 | Jynarque |
| Alexion Pharmaceuticals, INC. | $65.60 | 2022-2023 | Ultomiris |
| Opko Pharmaceuticals, LLC | $61.72 | 2021-2023 | Rayaldee |
| Akebia Therapeutics INC | $60.25 | 2021 | |
| Amgen INC. | $59.41 | 2022-2023 | Tavneos |
| Astrazeneca Pharmaceuticals LP | $56.34 | 2021-2023 | Farxiga |
| Calliditas Therapeutics US INC. | $40.12 | 2022-2023 | Tarpeyo |
| Aurinia Pharma U.S., INC. | $39.86 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.87 | 2024 | Jardiance |
| Pharmacosmos Therapeutics INC. | $19.32 | 2021 | |
| Mallinckrodt Hospital Products INC. | $17.02 | 2023 | Acthar |
| Nxstage Medical, INC. | $16.42 | 2025 | Liberty Select Cycler, Pureflow Sl, Nxstage System One |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sachiko Arakawa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.